Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard D Kim

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Expert Opinion on Investigational Drugs|January 26, 2024
Progress in the treatment of anal cancer: an overview of the latest investigational drugsJames Yu, Richard D Kim
Annals of Surgical Oncology|August 11, 2020
The Application of Circulating Tumor DNA in the Screening, Surveillance, and Treatment Monitoring of Colorectal CancerHao Xie, Richard D Kim
Genome Biology|September 4, 2004
Improving identification of differentially expressed genes in microarray studies using information from public databasesRichard D Kim, Peter J Park
Expert Opinion on Drug Safety|December 24, 2024
Safety of current treatments for advanced cholangiocarcinomaTiago Biachi de Castria, Richard D Kim
Cancer Management and Research|February 6, 2020
The Impact of Ramucirumab Treatment on Survival and Quality of Life in Patients with Gastric CancerRutika Mehta, Anuhya Kommalapati, Richard D Kim
Cancers|May 14, 2025
Targeting the KRAS Oncogene for Patients with Metastatic Colorectal CancerRuoyu Miao, James Yu, Richard D Kim
Current Oncology Reports|October 3, 2022
Immunotherapy in Biliary Tract Cancers: Where Are We?Aparna Kalyan, Harshit Khosla, Richard D Kim
Pragmatic and Observational Research|June 17, 2024
Real-World Effectiveness of First Line Lenvatinib Therapy in Advanced Hepatocellular Carcinoma: Current InsightsTiago Biachi de Castria, Richard D Kim
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|June 27, 2017
The Economic Value of Hybrid Single-photon Emission Computed Tomography With Computed Tomography Imaging in Pulmonary Embolism DiagnosisLauren K Toney, Richard D Kim, Swetha R Palli
Expert Opinion on Investigational Drugs|December 16, 2021
FGFR4 inhibitors for the treatment of hepatocellular carcinoma: a synopsis of therapeutic potentialHao Xie, Diego M Alem Glison, Richard D Kim
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Expert Opinion on Investigational Drugs|January 26, 2024
Progress in the treatment of anal cancer: an overview of the latest investigational drugsJames Yu, Richard D Kim
Annals of Surgical Oncology|August 11, 2020
The Application of Circulating Tumor DNA in the Screening, Surveillance, and Treatment Monitoring of Colorectal CancerHao Xie, Richard D Kim
Genome Biology|September 4, 2004
Improving identification of differentially expressed genes in microarray studies using information from public databasesRichard D Kim, Peter J Park
Expert Opinion on Drug Safety|December 24, 2024
Safety of current treatments for advanced cholangiocarcinomaTiago Biachi de Castria, Richard D Kim
Cancer Management and Research|February 6, 2020
The Impact of Ramucirumab Treatment on Survival and Quality of Life in Patients with Gastric CancerRutika Mehta, Anuhya Kommalapati, Richard D Kim
Cancers|May 14, 2025
Targeting the KRAS Oncogene for Patients with Metastatic Colorectal CancerRuoyu Miao, James Yu, Richard D Kim
Current Oncology Reports|October 3, 2022
Immunotherapy in Biliary Tract Cancers: Where Are We?Aparna Kalyan, Harshit Khosla, Richard D Kim
Pragmatic and Observational Research|June 17, 2024
Real-World Effectiveness of First Line Lenvatinib Therapy in Advanced Hepatocellular Carcinoma: Current InsightsTiago Biachi de Castria, Richard D Kim
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|June 27, 2017
The Economic Value of Hybrid Single-photon Emission Computed Tomography With Computed Tomography Imaging in Pulmonary Embolism DiagnosisLauren K Toney, Richard D Kim, Swetha R Palli
Expert Opinion on Investigational Drugs|December 16, 2021
FGFR4 inhibitors for the treatment of hepatocellular carcinoma: a synopsis of therapeutic potentialHao Xie, Diego M Alem Glison, Richard D Kim
Pageof 6